603 related articles for article (PubMed ID: 31998660)
1. Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.
Delgado-Diaz DJ; Tyssen D; Hayward JA; Gugasyan R; Hearps AC; Tachedjian G
Front Cell Infect Microbiol; 2019; 9():446. PubMed ID: 31998660
[TBL] [Abstract][Full Text] [Related]
2. Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisition.
Hearps AC; Tyssen D; Srbinovski D; Bayigga L; Diaz DJD; Aldunate M; Cone RA; Gugasyan R; Anderson DJ; Tachedjian G
Mucosal Immunol; 2017 Nov; 10(6):1480-1490. PubMed ID: 28401934
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory and antimicrobial properties differ between vaginal Lactobacillus isolates from South African women with non-optimal versus optimal microbiota.
Manhanzva MT; Abrahams AG; Gamieldien H; Froissart R; Jaspan H; Jaumdally SZ; Barnabas SL; Dabee S; Bekker LG; Gray G; Passmore JS; Masson L
Sci Rep; 2020 Apr; 10(1):6196. PubMed ID: 32277092
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis.
Aldunate M; Srbinovski D; Hearps AC; Latham CF; Ramsland PA; Gugasyan R; Cone RA; Tachedjian G
Front Physiol; 2015; 6():164. PubMed ID: 26082720
[TBL] [Abstract][Full Text] [Related]
5. Lactic acid enhances vaginal epithelial barrier integrity and ameliorates inflammatory effects of dysbiotic short chain fatty acids and HIV-1.
Schwecht I; Nazli A; Gill B; Kaushic C
Sci Rep; 2023 Nov; 13(1):20065. PubMed ID: 37973920
[TBL] [Abstract][Full Text] [Related]
6. Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression.
Delgado-Diaz DJ; Jesaveluk B; Hayward JA; Tyssen D; Alisoltani A; Potgieter M; Bell L; Ross E; Iranzadeh A; Allali I; Dabee S; Barnabas S; Gamieldien H; Blackburn JM; Mulder N; Smith SB; Edwards VL; Burgener AD; Bekker LG; Ravel J; Passmore JS; Masson L; Hearps AC; Tachedjian G
Microbiome; 2022 Aug; 10(1):141. PubMed ID: 36045402
[TBL] [Abstract][Full Text] [Related]
7. The role of lactic acid production by probiotic Lactobacillus species in vaginal health.
Tachedjian G; Aldunate M; Bradshaw CS; Cone RA
Res Microbiol; 2017; 168(9-10):782-792. PubMed ID: 28435139
[TBL] [Abstract][Full Text] [Related]
8. Vaginal microbiome.
Buchta V
Ceska Gynekol; 2018; 83(5):371-379. PubMed ID: 30848142
[TBL] [Abstract][Full Text] [Related]
9. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.
Mtshali A; San JE; Osman F; Garrett N; Balle C; Giandhari J; Onywera H; Mngomezulu K; Mzobe G; de Oliveira T; Rompalo A; Mindel A; Abdool Karim SS; Ravel J; Passmore JS; Abdool Karim Q; Jaspan HB; Liebenberg LJP; Ngcapu S
Front Immunol; 2021; 12():730986. PubMed ID: 34594336
[TBL] [Abstract][Full Text] [Related]
10. Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid.
Tyssen D; Wang YY; Hayward JA; Agius PA; DeLong K; Aldunate M; Ravel J; Moench TR; Cone RA; Tachedjian G
mSphere; 2018 Jul; 3(4):. PubMed ID: 29976641
[TBL] [Abstract][Full Text] [Related]
11. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
Kyongo JK; Crucitti T; Menten J; Hardy L; Cools P; Michiels J; Delany-Moretlwe S; Mwaura M; Ndayisaba G; Joseph S; Fichorova R; van de Wijgert J; Vanham G; Ariën KK; Jespers V
Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460
[TBL] [Abstract][Full Text] [Related]
12. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Lactobacillus crispatus isolates from Lactobacillus-dominated vaginal microbiomes with isolates from microbiomes containing bacterial vaginosis-associated bacteria.
Abdelmaksoud AA; Koparde VN; Sheth NU; Serrano MG; Glascock AL; Fettweis JM; Strauss JF; Buck GA; Jefferson KK
Microbiology (Reading); 2016 Mar; 162(3):466-475. PubMed ID: 26747455
[TBL] [Abstract][Full Text] [Related]
14. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R
Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498
[TBL] [Abstract][Full Text] [Related]
15. Bacterial vaginosis and the cervicovaginal immune response.
Mitchell C; Marrazzo J
Am J Reprod Immunol; 2014 Jun; 71(6):555-63. PubMed ID: 24832618
[TBL] [Abstract][Full Text] [Related]
16. Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review.
Plummer EL; Bradshaw CS; Doyle M; Fairley CK; Murray GL; Bateson D; Masson L; Slifirski J; Tachedjian G; Vodstrcil LA
PLoS One; 2021; 16(2):e0246953. PubMed ID: 33571286
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Over-The-Counter Lactic Acid Containing Vaginal Gels on the Integrity and Inflammatory State of the Vaginal Epithelium
Tyssen D; Hearps AC; Guntur K; Masson L; Cook S; Moulton SE; Ravel J; Bradshaw CS; Ayehunie S; Tachedjian G
Front Reprod Health; 2022; 4():915948. PubMed ID: 36303665
[TBL] [Abstract][Full Text] [Related]
18. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner.
Doerflinger SY; Throop AL; Herbst-Kralovetz MM
J Infect Dis; 2014 Jun; 209(12):1989-99. PubMed ID: 24403560
[TBL] [Abstract][Full Text] [Related]
19. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis.
Hoang T; Toler E; DeLong K; Mafunda NA; Bloom SM; Zierden HC; Moench TR; Coleman JS; Hanes J; Kwon DS; Lai SK; Cone RA; Ensign LM
PLoS Pathog; 2020 Jan; 16(1):e1008236. PubMed ID: 31971984
[TBL] [Abstract][Full Text] [Related]
20. Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense.
Valenti P; Rosa L; Capobianco D; Lepanto MS; Schiavi E; Cutone A; Paesano R; Mastromarino P
Front Immunol; 2018; 9():376. PubMed ID: 29545798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
